Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) by 18FDG-PET;Optimierung der bestrahlungsplanung beim nicht-kleinzelligen bronchialkarzinom (NSCLC) mit hilfe von 18FDG-PET

NuklearMedizin

Volumn 41, Issue 5, 2002, Pages 217-220

  Schmidt, Sylvia ^a   Nestle, U ^a   Walter, K ^a   Licht, N ^a   Ukena, D ^a   Schnabel, K ^a   Kirsch, C M ^a  

^a Radiol/Nuklearmed Gemeins Rasar   (Germany)

Author keywords

Atelektasis; FDG PET; Lung cancer; NSCLC; Radiotherapy planning

Indexed keywords

ARTICLE; ATELECTASIS; BRONCHOSCOPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG VENTILATION; RADIATION FIELD; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0036797313     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625290     Document Type: Article

References (17)

1. Bury T, Paulus P, Dowlati A et al. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. Eur resp J 1996; 9: 2560-4.
2. Debois M, Fossard A, Vansteenkiste J et al. Impact of PET scan in lung cancer radiotherapy planning. Radiother Oncol 1998; 48 (Suppl. 1): S13.
3. Delbeke D. Oncological applications of FDG-PET imaging. J Nucl Med 1999; 40: 1706-15.
4. 18F FDG positron emission tomography (PET). Thorax 1997; 52: 438-41.
5. 18F-FDG-PET. J Nucl Med 1996; 19: 416-21.
6. Hudson H, Larkin R. Accelerated image reconstruction using ordered subset of projection data. IEEE Trans Med Img 1994; 13: 601-9.
7. Internal commission on radiation units and measurements (ICRU) Report 50: Prescribing, recording and reporting photon beam therapy, Bethesda ICRU 1993.
8. 18F-fluoro-deoxy-glucose positron emission tomographic imaging to radio-therapy planning in lung cancer. Lung Cancer 1998; 19: 167-77.
9. Kubota R, Yamada S, Kubota K et al. Intratumoral distribution of F-18 fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-80.
10. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primery tumors (UPT). Eur J Cancer 1999; 35: 1076-82.
11. Munley MT, Scarfone MS, Marks LB et al. Multimodality nuclear medicine imaging in radiation treatment planning for lung cancer: challenges and prospects. Int J Radiat Oncol Biol Phys 1996; 36: 188.
12. 18F-FDG in a brain abscess: PET study. J Comput Assist Tomogr 1990; 13: 829-31.
13. Steinert HC, Hauser M, Allemann F et al. Non-small cell lung cancer: nodal staging with FDG-PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-6.
14. Vansteenkiste JF, Stroobants SG, DeLeyn PR et al., Leuven Lung Cancer Group. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small-cell lung cancer: a prospective analysis of 50 cases. Chest 1997; 112: 1480-6.
15. 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small-cell lung cancer. Radiother Oncol 2000; 55: 317-24.
16. Weber WA,Avril N, Schwaiger M. Relevance of positron emission tomography (PET) in oncology. Strahlenther Onkol 1999; 175: 356-73.
17. 18FDG PET scans. Radiology 1996: 201: 873-6.